MNAZYME
LIVE

Serial Number

79099130

Owner

SpeeDx Pty Ltd

Attorney

David M. Perry

Filing Date

Jan 7, 2011

Add to watchlist:

No watchlists yet
View on USPTO

MNAZYME Trademark

Serial Number: 79099130 • Registration: 4148404

MNAZYME is a trademark filed by SpeeDx Pty Ltd on January 7, 2011. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). The application is currently registered and active.

Owner Contact Info

SpeeDx Pty Ltd (21 trademarks)

Suite G16, National Innovation Centre,

Entity Type: 82

Trademark Details

Filing Date

January 7, 2011

Registration Date

May 29, 2012

Published for Opposition

March 13, 2012

Cancellation Date

January 7, 2021

Goods & Services

pharmaceutical and veterinary preparations and substances for the diagnosis of diseases or detection or identification of pathogens; reagents for medical and veterinary use; nucleic acid amplification reagents for medical use; nucleic acid sequencing programs for medical use; chemical preparations containing enzymes for medical purposes for the diagnosis of diseases or detection or identification of pathogens; chemical preparations containing enzymes for pharmaceutical, veterinary and medical purposes for the diagnosis of diseases or detection or identification of pathogens; enzymes for pharmaceutical, veterinary and medical purposes; medical kits consisting of catalytic DNA molecules and associated detection reagents for the diagnosis of diseases, for detection and identification of pathogens, for the detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, and immune-suppression and immune disorders, for genotyping, analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy; diagnostic reagents for medical or veterinary use; biological chemical test kits for medical laboratory use in analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression, immune disorders

chemicals used in industry, science, photography; chemicals used in agriculture, horticulture and forestry except fungicides, herbicides, insecticides, and parasiticides; chemical reagents and reactants for non-medical purposes; enzymes for use in the biotechnology industry; nucleic acid sequences, other than medical and veterinary purposes; nucleic recombinant acids; nucleic acids; DNA polymerase, other than medical and veterinary purposes; chemicals used in food processing and screening; microbial chemicals used in environmental monitoring

surgical and medical apparatus and instruments, namely, surgical apparatus and instruments for medical or veterinary use; diagnostic testing apparatus and instruments for medical purposes, namely, for the detection of diseases, detection and identification of pathogens, detection of antibiotic resistance, for the analysis of gene expression, protein expression, metabolite expression, inflammation, immune-suppression and immune disorders, for genotyping, for analysis of polymorphisms, detection of acquired or inherited genetic mutations, detection and analysis of epigenetic alterations, and for analysis of response to therapy

Filing History

NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG E-MAILED
Nov 28, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 28, 2021 DETH
TOTAL INVALIDATION PROCESSED BY THE IB
Oct 18, 2019 INNT
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Sep 16, 2019 INTS
INVALIDATION PROCESSED
Sep 16, 2019 INPC
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 4, 2019 INTR
CANCELLED SECTION 71
Jan 4, 2019 C71T
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
May 29, 2017 REM3
NEW REPRESENTATIVE AT IB RECEIVED
Mar 10, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Feb 9, 2017 NREP
NEW REPRESENTATIVE AT IB RECEIVED
Dec 16, 2016 NREP
NOTIFICATION PROCESSED BY IB
Nov 25, 2012 GPNX
FINAL DECISION TRANSACTION PROCESSED BY IB
Sep 15, 2012 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Aug 30, 2012 FICS
FINAL DISPOSITION PROCESSED
Aug 30, 2012 FIMP
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Aug 29, 2012 FICR
REGISTERED-PRINCIPAL REGISTER
May 29, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 13, 2012 NPUB
PUBLISHED FOR OPPOSITION
Mar 13, 2012 PUBO
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Feb 22, 2012 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Feb 22, 2012 OP2R
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 22, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Feb 8, 2012 PREV
ASSIGNED TO LIE
Feb 7, 2012 ALIE
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 24, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jan 17, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jan 17, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jan 17, 2012 TROA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jan 3, 2012 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 3, 2012 REAP
REFUSAL PROCESSED BY IB
Aug 7, 2011 RFNP
APPLICATION FILING RECEIPT MAILED
Jul 20, 2011 MAFR
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jul 19, 2011 RFCS
REFUSAL PROCESSED BY MPU
Jul 19, 2011 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Jul 18, 2011 RFCR
NON-FINAL ACTION WRITTEN
Jul 17, 2011 CNRT
ASSIGNED TO EXAMINER
Jul 16, 2011 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jul 16, 2011 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Jul 14, 2011 REPR